Genovese Burford & Brothers Wealth & Retirement Plan Management’s Kindred Biosciences, Inc. KIN Stock Holding History

Genovese Burford & Brothers Wealth & Retirement Plan Management’s Portfolio KIN Stock Details KIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,000	Closed	-$11K	–	416
2018 Q2	$11K	Hold	1,000	–	–	﹤0.01%	314
2018 Q1	$9K	Buy	+1,000	New	+$8.77K	﹤0.01%	332

Other funds holding KIN

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Genovese Burford & Brothers Wealth & Retirement Plan Management's KIN Position: Q3 2018 in Review

Genovese Burford & Brothers Wealth & Retirement Plan Management sold out of Kindred Biosciences, Inc. (KIN) in Q3 2018, closing a stake of 1,000 shares — an estimated $11K sold.

Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in KIN in Q1 2018 and held it in 2 quarters. The position peaked at $11K in Q2 2018. 81 funds tracked by Wall St. Rank hold KIN as of Q3 2018.

Genovese Burford & Brothers Wealth & Retirement Plan Management reported no remaining Kindred Biosciences, Inc. position as of Q3 2018 after selling out during the quarter.
Genovese Burford & Brothers Wealth & Retirement Plan Management sold 1,000 Kindred Biosciences, Inc. shares in Q3 2018, an estimated $11K.
Genovese Burford & Brothers Wealth & Retirement Plan Management first reported a position in Kindred Biosciences, Inc. in Q1 2018 and held it in 2 quarters.
Genovese Burford & Brothers Wealth & Retirement Plan Management's Kindred Biosciences, Inc. position peaked at $11K in Q2 2018.
81 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2018.

Based on Genovese Burford & Brothers Wealth & Retirement Plan Management's 13F filing for Q3 2018, filed 13 Nov 2018.